Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor
In Reply.—While we disagree with some of the arguments put forth by Dr Balano and colleagues we do not challenge their premise that the reliability of rapid testing for HIV-1 is less than ideal, particularly in low-prevalence communities (although ongoing technical advances in the field will undoubtedly improve the tests' reliability in the future). Indeed, we believe that all women who consider rapid screening should be aware of all the data that the authors bring to the fore regarding the reliability of tests and the risks of treatment. However, we differ with the authors' supposition that because treatment may be shown ultimately to have been unnecessary, it should no longer be left to individual women to decide for themselves whether they wish to be tested and treated.
Minkoff H, O'Sullivan MJ. Publishing Research. JAMA. 1998;280(19):1664. doi:10-1001/pubs.JAMA-ISSN-0098-7484-280-19-jbk1118